Combination of autoantibodies against different histone proteins influences complement-dependent phagocytosis of necrotic cell material by polymorphonuclear leukocytes in systemic lupus erythematosus

Journal of Rheumatology

Volumn 39, Issue 8, 2012, Pages 1619-1627

  Gullstrand, Birgitta ^b   Lefort, Malin H ^a   Tydén, Helena ^a   Jönsen, Andreas ^a   Lood, Christian ^a   Johansson, Åsa ^b   Jacobsen, Søren ^c   Truedsson, Lennart ^b   Bengtsson, Anders A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Antihistone antibody; Autoantibody; Complement; Polymorphonuclear leukocytes; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; DNA ANTIBODY; FC GAMMA RECEPTOR IIIB; FC RECEPTOR; FC RECEPTOR IIA; HISTONE; HISTONE ANTIBODY; HISTONE H1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DEATH; CELL PHAGOCYTOSIS; CELL TRANSPORT; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; COMPLEMENT SYSTEM PROTEINS; FEMALE; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NECROSIS; NEUTROPHILS; PHAGOCYTOSIS; PROSPECTIVE STUDIES;

EID: 84864561878     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111511     Document Type: Article

References (36)

1. Oates JC, Gilkeson GS. Mediators of injury in lupus nephritis. Curr Opin Rheumatol 2002;14:498-503. (Pubitemid 34953785)
2. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30. (Pubitemid 24091790)
3. Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptotic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998;7:113-8. (Pubitemid 28107976)
4. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50. (Pubitemid 28313427)
5. Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 2005;4:189-94. (Pubitemid 40704701)
6. Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements; the tart cell and the L.E. cell. Mayo Clin Proc 1948;23:25-8.
7. Haserick JR, Lewis LA. Blood factor in acute disseminated lupus erythematosus; induction of specific antibodies against L.E. factor. Blood 1950;5:718-22.
8. Miescher P, Strassle R. New serological methods for the detection of the L.E. factor. Vox Sang 1957;2:283-7.
9. Holman HR, Kunkel HG. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 1957;126:162-3.
10. Friou GJ. Identification of the nuclear component of the interaction of lupus erythematosus globulin and nuclei. J Immunol 1958;80:476-81.
11. Aisenberg AC. Studies on the mechanism of the lupus erythematosus (L.E.) phenomenon. J Clin Invest 1959;38:325-33.
12. Schett G, Steiner G, Smolen JS. Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation. Arthritis Rheum 1998;41:1446-55. (Pubitemid 28373125)
13. Böhm I. Flow cytometric analysis of the LE cell phenomenon. Autoimmunity 2004;37:37-44. (Pubitemid 38185908)
14. Gioud M, Kaci MA, Monier JC. Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool. Arthritis Rheum 1982;25:407-13. (Pubitemid 12158949)
15. Krippner H, Springer B, Merle S, Pirlet K. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus. Clin Exp Immunol 1984;58:49-56. (Pubitemid 14029123)
16. Cohen MG, Pollard KM, Webb J. Antibodies to histones in systemic lupus erythematosus: Prevalence, specificity, and relationship to clinical and laboratory features. Ann Rheum Dis 1992;51:61-6.
17. Schett G, Rubin RL, Steiner G, Hiesberger H, Muller S, Smolen J. The lupus erythematosus cell phenomenon: Comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera. Arthritis Rheum 2000;43:420-8. (Pubitemid 30395753)
18. Stummvoll GH, Fritsch RD, Meyer B, Hoefler E, Aringer M, Smolen JS, et al. Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus. Ann Rheum Dis 2009;68:110-6.
19. Robinson JJ, Watson F, Phelan M, Bucknall RC, Edwards SW. Activation of neutrophils by soluble and insoluble immunoglobulin aggregates from synovial fluid of patients with rheumatoid arthritis. Ann Rheum Dis 1993;52:347-53. (Pubitemid 23165972)
20. Voice JK, Lachmann PJ. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes. Eur J Immunol 1997;27:2514-23. (Pubitemid 27453838)
21. Mantovani B. Different roles of IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes. J Immunol 1975;115:15-7.
22. Ohkuro M, Ogura-Masaki M, Kobayashi K, Sakai M, Takahashi K, Nagasawa S. Effect of iC3b binding to immune complexes upon the phagocytic response of human neutrophils: Synergistic functions between Fc gamma R and CR3. FEBS Lett 1995;373:189-92.
23. Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM. Fc-gamma and complement receptors: Expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients. Lupus 2002;11:240-8. (Pubitemid 34506729)
24. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
25. Gladman DD, Ibanez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002;29:288-91. (Pubitemid 34118775)
26. Gullstrand B, Mårtensson U, Sturfelt G, Bengtsson AA, Truedsson L. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol 2009;156:303-11.
27. Collin M, Olsen A. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 2001;20:3046-55. (Pubitemid 32611992)
28. Lood C, Allhorn M, Lood R, Gullstrand B, Olin AI, Rönnblom L, et al. IgG glycan hydrolysis by EndoS diminishes the pro-inflammatory properties of immune complexes from patients with SLE - A possible new treatment? Arthritis Rheum 2012 Mar 5. [Epub ahead of print]
29. Munoz LE, Janko C, Grossmayer GE, Frey B, Voll RE, Kern P, et al. Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 2009;60:1733-42.
30. Rekvig OP, Hannestad K. Lupus erythematosus (LE) factors recognize both nucleosomes and viable human leucocytes. Scand J Immunol 1981;13:597-604. (Pubitemid 11112502)
31. Schmidt-Acevedo S, Perez-Romano B, Ruiz-Arguelles A. "LE cells" result from phagocytosis of apoptotic bodies induced by antinuclear antibodies. J Autoimmun 2000;15:15-20. (Pubitemid 32289458)
32. Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity 2007;40:560-6. (Pubitemid 350302182)
33. Böhm I. LE cell phenomenon: Nuclear IgG deposits inhibit enzymatic cleavage of the nucleus of damaged cells and support its phagocytic clearance by PMN. Biomed Pharmacother 2004;58:196-201. (Pubitemid 38479925)
34. Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA 2010;107:9813-8.
35. Papayannopoulos V, Zychlinsky A. NETs: A new strategy for using old weapons. Trends Immunol 2009;30:513-21.
36. Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 2009;5:e1000639.